Showing results (311-320 of 367) with videos related to
Sort By:
Pageof 37
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 27, 2021
Role of microbiota-derived short-chain fatty acids in cancer development and preventionRasoul Mirzaei, Azam Afaghi, Sajad Babakhani, et al.Journal of Neurosurgery|October 25, 2023
Oncolytic viral therapy: a review and promising future directionsRamya Reddy, Sandra C Yan, Zahra Hasanpour Segherlou, et al.Expert Review of Endocrinology & Metabolism|May 7, 2024
Hormonal influences on cerebral aneurysms: unraveling the complex connectionsZahra Hasanpour Segherlou, Mahdieh Shakeri-Darzekonani, Armin Khavandegar, et al.BMC Pulmonary Medicine|August 16, 2008
Angiotensin-converting enzyme genotype and late respiratory complications of mustard gas exposureAli Reza Hosseini-Khalili, Julian Thompson, Anthony Kehoe, et al.Atmospheric Environment (Oxford, England : 1994)|October 15, 2014
Determinants of the Spatial Distributions of Elemental Carbon and Particulate Matter in Eight Southern Californian CommunitiesRobert Urman, James Gauderman, Scott Fruin, et al.The Journal of Clinical Endocrinology and Metabolism|March 26, 2009
Increased bone marrow fat in anorexia nervosaMiriam A Bredella, Pouneh K Fazeli, Karen K Miller, et al.Current Medicinal Chemistry|February 28, 2023
Efficacy and Safety of Alirocumab and Evolocumab as Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Familial Hypercholesterolemia: A Systematic Review and Meta-AnalysisGhasem Ghasempour, Fahimeh Zamani-Garmsiri, Farhad Shaikhnia, et al.Immunology Letters|November 28, 2017
Inhibition of tumor growth by mouse ROR1 specific antibody in a syngeneic mouse tumor modelHadi Hassannia, Mohammad Mehdi Amiri, Farhad Jadidi-Niaragh, et al.Journal of Experimental Orthopaedics|July 9, 2024
Anterior cruciate ligament-Return to sport after injury scale brief version after ACL reconstruction: Persian translation, cross-cultural adaptation and validationNasim Eshraghi, Peyman Mirghaderi, Reza Omid, et al.Psychopharmacology|September 10, 2013
A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophreniaMehdi Farokhnia, Maryam Sabzabadi, Hossein Pourmahmoud, et al.Pageof 37